Barchart on Facebook
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Spring Bank Ph CS (SBPH)

Spring Bank Ph CS (SBPH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 18,648
  • Shares Outstanding, K 17,267
  • Annual Sales, $ 0 K
  • Annual Income, $ -24,100 K
  • 60-Month Beta 1.07
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.84
Trade SBPH with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/20
See More
  • Average Estimate -0.25
  • Number of Estimates 1
  • High Estimate -0.25
  • Low Estimate -0.25
  • Prior Year -0.42
  • Growth Rate Est. (year over year) +40.48%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.0500 +5.20%
on 10/28/20
1.5200 -27.33%
on 10/14/20
-0.3154 (-22.21%)
since 09/29/20
3-Month
1.0500 +5.20%
on 10/28/20
2.5000 -55.82%
on 07/30/20
-0.9754 (-46.89%)
since 07/29/20
52-Week
0.8000 +38.07%
on 03/16/20
4.8000 -76.99%
on 12/02/19
-1.9954 (-64.37%)
since 10/29/19

Most Recent Stories

More News
ALERT: Halper Sadeh LLP Continues to Investigate the Following Mergers; Shareholders are Encouraged to Contact the Firm - AMAG, SBPH, VAR, SINA, GARS

, /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, is investigating:

AMAG : 13.71 (unch)
SBPH : 1.1046 (+2.28%)
VAR : 172.28 (-0.08%)
SINA : 42.67 (-0.02%)
GARS : 3.88 (-1.52%)
Spring Bank Class Action: Halper Sadeh LLP Announces Filing of Shareholder Class Action Lawsuit Against Spring Bank Pharmaceuticals, Inc.; Investors Are Encouraged to Contact the Firm - SBPH

Halper Sadeh LLP, a global investor rights law firm, announces the filing of a shareholder class action lawsuit against Spring Bank Pharmaceuticals, Inc. (NASDAQ: SBPH) in connection with its merger with...

SBPH : 1.1046 (+2.28%)
Rigrodsky & Long, P.A. Files Class Action Suit Against Spring Bank Pharmaceuticals, Inc.

Rigrodsky & Long, P.A. announces that it has filed a class action complaint in the United States District Court for the District of Delaware on behalf of holders of Spring Bank Pharmaceuticals, Inc. ("Spring...

SBPH : 1.1046 (+2.28%)
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of SBPH, NTN, PTI and GLIBA Mergers

Rigrodsky & Long, P.A. announces that it is investigating:

PTI : 1.0100 (-0.98%)
SBPH : 1.1046 (+2.28%)
SHAREHOLDER ALERT: WeissLaw LLP Investigates Spring Bank Pharmaceuticals, Inc.

, /PRNewswire/ --  is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Spring Bank Pharmaceuticals, Inc. ("SBPH" or the "Company") (NASDAQ:...

SBPH : 1.1046 (+2.28%)
MERGER ALERT - SBPH, IMMU, and MNTA: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Mergers of these Companies

NEW YORK, NY / ACCESSWIRE / September 21, 2020 / The following statement is being issued by Levi & Korsinsky, LLP:

SBPH : 1.1046 (+2.28%)
IMMU : 87.86 (+0.05%)
MNTA : 52.48 (-0.02%)
MERGER INVESTIGATION ALERT: Halper Sadeh LLP Reminds Shareholders About Its Ongoing Investigations; Investors are Encouraged to Contact the Firm - ONDK, MR, SBPH, JCAP

, /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, is investigating:

ENVA : 16.15 (-3.58%)
ONDK : 1.8300 (-3.17%)
MR : 5.15 (-2.28%)
SBPH : 1.1046 (+2.28%)
JCAP : 17.27 (+0.06%)
MERGER ALERT - SBPH and VRTU: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Mergers of these Companies

NEW YORK, NY / ACCESWIRE / September 17, 2020 / The following statement is being issued by Levi & Korsinsky, LLP:

SBPH : 1.1046 (+2.28%)
VRTU : 50.10 (-0.04%)
Lifshitz Law Firm, P.C. Announces Investigation of Cellular Biomedicine Group, Inc. (NASDAQ: CBMG), GCI Liberty, Inc. (NASDAQ: GLIBA), Maxim Integrated Products (NASDAQ:MXIM), National General Holdings Corp. (NASDAQ: NGHC), Pfenex Inc. (NYSE: PFNX), Spring Bank Pharmaceuticals, Inc. (NASDAQ: SBPH), and Varian Medical Systems, Inc. (NYSE: VAR)

, /PRNewswire/ --

MDSY : 0.73 (+4.29%)
CBMG : 18.28 (+0.33%)
GLIBA : 78.22 (+0.29%)
JCAP : 17.27 (+0.06%)
ADI : 118.48 (+1.73%)
NGHC : 33.99 (+0.12%)
OTEL : 11.51 (+0.17%)
PFNX : 12.75 (-0.08%)
SBPH : 1.1046 (+2.28%)
VAR : 172.28 (-0.08%)
MXIM : 70.19 (+2.06%)
Moore Kuehn Encourages SBPH, PFNX, VAR, and PRNB Investors to Contact Law Firm

Moore Kuehn, PLLC, a securities litigation law firm located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed mergers are fair to shareholders....

SBPH : 1.1046 (+2.28%)
PFNX : 12.75 (-0.08%)
VAR : 172.28 (-0.08%)
PRNB : 100.05 (+0.10%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strengthening short term outlook on maintaining the current direction.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Spring Bank Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of therapeutics using its proprietary small molecule nucleic acid hybrid chemistry platform. The company is developing SB 9200, for the treatment of viral diseases, including...

See More

Key Turning Points

2nd Resistance Point 1.1982
1st Resistance Point 1.1514
Last Price 1.1046
1st Support Level 1.0589
2nd Support Level 1.0132

See More

52-Week High 4.8000
Fibonacci 61.8% 3.2720
Fibonacci 50% 2.8000
Fibonacci 38.2% 2.3280
Last Price 1.1046
52-Week Low 0.8000

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar